Research led Terry J. Smith, M.D., and Raymond Douglas, M.D., Ph.D., while at the University of Michigan Kellogg Eye Center, shows success of teprotumumab in safely reducing disfiguring eye symptoms of Graves’ eye disease. The disease is characterized by inflammation and a buildup of tissue around the eyes that cause them to bulge painfully...